Cases of human fascioliasis in India: tip of the iceberg.
This report presents two cases of human fascioliasis from different states in India. Although only few cases of human fascioliasis have been reported from India previously, both these cases were encountered within a span of three months at this tertiary care centre. Case 1 had significant symptoms with episodes of fever, abdominal pain and eosiniphilia and underwent multiple diagnostic procedures before the correct diagnosis was reached. Case 2, who had few symptoms, had fascioliasis diagnosed with minimal evaluation. These different presentations seen at two ends of the clinical spectrum of disease along with findings of peripheral eosinophilia, and radiological findings led to a presumptive diagnosis that was then confirmed by microscopic examination of bile. Morphometric analysis of ova from these cases was suggestive of infestation with F. gigantica or a F. gigantica-like hybrid. Both patients were treated with triclabendazole which was imported from Geneva. The need to be aware of the possibility of occurrence of this disease and the inclusion of drugs used for treating the disease, in the Indian drug list, should be emphasized.
Department of Medicine and Infectious Diseases, Christian Medical College, Vellore, India.
J
J
Ramachandran
S S R
SS
Ajjampur
A
A
Chandramohan
G M
GM
Varghese
D015746:Abdominal Pain / Q000209:etiology; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001706:Biopsy; D005210:Fasciola hepatica / Q000302:isolation & purification*; D005211:Fascioliasis / Q000175:diagnosis* / Q000188:drug therapy* / Q000469:parasitology; D005260:Female; D006529:Hepatomegaly / Q000209:etiology; D006801:Humans; D007194:India; D008875:Middle Aged; D016896:Treatment Outcome; D000077682:Triclabendazole; D014463:Ultrasonography
D000871:Anthelmintics; D001562:Benzimidazoles; D000077682:Triclabendazole